This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riese, D. J.
Right arrow Articles by Stern, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riese, D. J., 2nd
Right arrow Articles by Stern, D. F.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 10 1995, 5770-5776, Vol 15, No. 10
Copyright © 1995, American Society for Microbiology

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family [published erratum appears in Mol Cell Biol 1996 Feb;16(2):735]

DJ Riese 2nd, TM van Raaij, GD Plowman, GC Andrews and DF Stern
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.

Deregulated signaling by the four members of the epidermal growth factor receptor tyrosine kinase family (erbB family) is implicated in the genesis or progression of human cancers. However, efforts to analyze signaling by these receptors have been hampered by the diversity of ligands and extensive interreceptor cross talk. We have expressed the four human erbB family receptors, singly and in pairwise combinations, in a pro-B-lymphocyte cell line (Ba/F3) and investigated the range of interactions activated by the epidermal growth factor homology domain of the agonist neuregulin beta. The results provide the first comprehensive analysis of the response of this receptor family to a single peptide agonist. This peptide induced complex patterns of receptor tyrosine phosphorylation and regulation of Ba/F3 cell survival and proliferation. These data demonstrate the existence of several previously undocumented receptor interactions driven by neuregulin.


This article has been cited by other articles:

  • Gilmore, J. L., Gonterman, R. M., Menon, K., Lorch, G., Riese, D. J. II, Robling, A., Foley, J. (2009). Reconstitution of Amphiregulin-Epidermal Growth Factor Receptor Signaling in Lung Squamous Cell Carcinomas Activates PTHrP Gene Expression and Contributes to Cancer-Mediated Diseases of the Bone. Mol Cancer Res 7: 1714-1728 [Abstract] [Full Text]  
  • Naresh, A., Thor, A. D., Edgerton, S. M., Torkko, K. C., Kumar, R., Jones, F. E. (2008). The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis. Cancer Res. 68: 6387-6395 [Abstract] [Full Text]  
  • Honjo, Y., Kniss, J., Eisen, J. S. (2008). Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons. Development 135: 2615-2625 [Abstract] [Full Text]  
  • Pu, J., McCaig, C. D., Cao, L., Zhao, Z., Segall, J. E., Zhao, M. (2007). EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells. J. Cell Sci. 120: 3395-3403 [Abstract] [Full Text]  
  • Maegawa, M., Takeuchi, K., Funakoshi, E., Kawasaki, K., Nishio, K., Shimizu, N., Ito, F. (2007). Growth Stimulation of Non-Small Cell Lung Cancer Cell Lines by Antibody against Epidermal Growth Factor Receptor Promoting Formation of ErbB2/ErbB3 Heterodimers. Mol Cancer Res 5: 393-401 [Abstract] [Full Text]  
  • Wehrman, T. S., Raab, W. J., Casipit, C. L., Doyonnas, R., Pomerantz, J. H., Blau, H. M. (2006). A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proc. Natl. Acad. Sci. USA 103: 19063-19068 [Abstract] [Full Text]  
  • Dammann, C. E. L., Nassimi, N., Liu, W., Nielsen, H. C. (2006). ErbB receptor regulation by dexamethasone in mouse type II epithelial cells. Eur Respir J 28: 1117-1123 [Abstract] [Full Text]  
  • Ramsauer, V. P., Pino, V., Farooq, A., Carothers Carraway, C. A., Salas, P. J.I., Carraway, K. L. (2006). Muc4-ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2. Mol. Biol. Cell 17: 2931-2941 [Abstract] [Full Text]  
  • Zhan, L., Xiang, B., Muthuswamy, S. K. (2006). Controlled Activation of ErbB1/ErbB2 Heterodimers Promote Invasion of Three-Dimensional Organized Epithelia in an ErbB1-Dependent Manner: Implications for Progression of ErbB2-Overexpressing Tumors.. Cancer Res. 66: 5201-5208 [Abstract] [Full Text]  
  • Yang, C., Liu, Y., Lemmon, M. A., Kazanietz, M. G. (2006). Essential Role for Rac in Heregulin {beta}1 Mitogenic Signaling: a Mechanism That Involves Epidermal Growth Factor Receptor and Is Independent of ErbB4. Mol. Cell. Biol. 26: 831-842 [Abstract] [Full Text]  
  • Xue, C., Liang, F., Mahmood, R., Vuolo, M., Wyckoff, J., Qian, H., Tsai, K.-L., Kim, M., Locker, J., Zhang, Z.-Y., Segall, J. E. (2006). ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis. Cancer Res. 66: 1418-1426 [Abstract] [Full Text]  
  • Konecny, G. E., Pegram, M. D., Venkatesan, N., Finn, R., Yang, G., Rahmeh, M., Untch, M., Rusnak, D. W., Spehar, G., Mullin, R. J., Keith, B. R., Gilmer, T. M., Berger, M., Podratz, K. C., Slamon, D. J. (2006). Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells. Cancer Res. 66: 1630-1639 [Abstract] [Full Text]  
  • McCabe, A., Dolled-Filhart, M., Camp, R. L., Rimm, D. L. (2005). Automated Quantitative Analysis (AQUA) of In Situ Protein Expression, Antibody Concentration, and Prognosis. JNCI J Natl Cancer Inst 97: 1808-1815 [Abstract] [Full Text]  
  • Benlimame, N., He, Q., Jie, S., Xiao, D., Xu, Y. J., Loignon, M., Schlaepfer, D. D., Alaoui-Jamali, M. A. (2005). FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. JCB 171: 505-516 [Abstract] [Full Text]  
  • Howard, B., Panchal, H., McCarthy, A., Ashworth, A. (2005). Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification. Genes Dev. 19: 2078-2090 [Abstract] [Full Text]  
  • Dote, H., Cerna, D., Burgan, W. E., Camphausen, K., Tofilon, P. J. (2005). ErbB3 Expression Predicts Tumor Cell Radiosensitization Induced by Hsp90 Inhibition. Cancer Res. 65: 6967-6975 [Abstract] [Full Text]  
  • Hu, Y. P., Venkateswarlu, S., Sergina, N., Howell, G., Clair, P. St., Humphrey, L. E., Li, W., Hauser, J., Zborowska, E., Willson, J. K. V., Brattain, M. G. (2005). Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells. J. Biol. Chem. 280: 27383-27392 [Abstract] [Full Text]  
  • Nethery, D. E., Moore, B. B., Minowada, G., Carroll, J., Faress, J. A., Kern, J. A. (2005). Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice. J. Appl. Physiol. 99: 298-307 [Abstract] [Full Text]  
  • Gregory, C. W., Whang, Y. E., McCall, W., Fei, X., Liu, Y., Ponguta, L. A., French, F. S., Wilson, E. M., Earp, H. S. III (2005). Heregulin-Induced Activation of HER2 and HER3 Increases Androgen Receptor Transactivation and CWR-R1 Human Recurrent Prostate Cancer Cell Growth. Clin. Cancer Res. 11: 1704-1712 [Abstract] [Full Text]  
  • DiGiovanna, M. P., Stern, D. F., Edgerton, S. M., Whalen, S. G., Moore, D. II, Thor, A. D. (2005). Relationship of Epidermal Growth Factor Receptor Expression to ErbB-2 Signaling Activity and Prognosis in Breast Cancer Patients. JCO 23: 1152-1160 [Abstract] [Full Text]  
  • Brown, N., Deb, K., Paria, B. C., Das, S. K., Reese, J. (2004). Embryo-Uterine Interactions via the Neuregulin Family of Growth Factors During Implantation in the Mouse. Biol. Reprod. 71: 2003-2011 [Abstract] [Full Text]  
  • Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L., Jones, F. E. (2004). The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. JCB 167: 469-478 [Abstract] [Full Text]  
  • Li, Q., Ahmed, S., Loeb, J. A. (2004). Development of an Autocrine Neuregulin Signaling Loop with Malignant Transformation of Human Breast Epithelial Cells. Cancer Res. 64: 7078-7085 [Abstract] [Full Text]  
  • Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., Manning, G. (2004). The mouse kinome: Discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. USA 101: 11707-11712 [Abstract] [Full Text]  
  • Jackson, J. G., St. Clair, P., Sliwkowski, M. X., Brattain, M. G. (2004). Blockade of Epidermal Growth Factor- or Heregulin-Dependent ErbB2 Activation with the Anti-ErbB2 Monoclonal Antibody 2C4 Has Divergent Downstream Signaling and Growth Effects. Cancer Res. 64: 2601-2609 [Abstract] [Full Text]  
  • Gomez, A., Volff, J.-N., Hornung, U., Schartl, M., Wellbrock, C. (2004). Identification of a Second egfr Gene in Xiphophorus Uncovers an Expansion of the Epidermal Growth Factor Receptor Family in Fish. Mol Biol Evol 21: 266-275 [Abstract] [Full Text]  
  • Janmaat, M. L., Giaccone, G. (2003). Small-Molecule Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. The Oncologist 8: 576-586 [Abstract] [Full Text]  
  • Ramsauer, V. P., Carraway, C. A. C., Salas, P. J. I., Carraway, K. L. (2003). Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells. J. Biol. Chem. 278: 30142-30147 [Abstract] [Full Text]  
  • Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F. III, Hynes, N. E. (2003). The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl. Acad. Sci. USA 100: 8933-8938 [Abstract] [Full Text]  
  • Grunwald, V., Hidalgo, M. (2003). Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment. JNCI J Natl Cancer Inst 95: 851-867 [Abstract] [Full Text]  
  • Rowinsky, E. K. (2003). Challenges of Developing Therapeutics That Target Signal Transduction in Patients With Gynecologic and Other Malignancies. JCO 21: 175s-186 [Abstract] [Full Text]  
  • Stortelers, C., van der Woning, S. P., Jacobs-Oomen, S., Wingens, M., van Zoelen, E. J. J. (2003). Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-like Ligands. J. Biol. Chem. 278: 12055-12063 [Abstract] [Full Text]  
  • Yen, L., Benlimame, N., Nie, Z.-R., Xiao, D., Wang, T., Moustafa, A.-E. A., Esumi, H., Milanini, J., Hynes, N. E., Pages, G., Alaoui-Jamali, M. A. (2002). Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers. Mol. Biol. Cell 13: 4029-4044 [Abstract] [Full Text]  
  • Penuel, E., Akita, R. W., Sliwkowski, M. X. (2002). Identification of a Region within the ErbB2/HER2 Intracellular Domain That Is Necessary for Ligand-independent Association. J. Biol. Chem. 277: 28468-28473 [Abstract] [Full Text]  
  • Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R., Mekada, E. (2002). Ligand-independent Dimer Formation of Epidermal Growth Factor Receptor (EGFR) Is a Step Separable from Ligand-induced EGFR Signaling. Mol. Biol. Cell 13: 2547-2557 [Abstract] [Full Text]  
  • Penington, D. J., Bryant, I., Riese, D. J. II (2002). Constitutively Active ErbB4 and ErbB2 Mutants Exhibit Distinct Biological Activities. Cell Growth Differ. 13: 247-256 [Abstract] [Full Text]  
  • Tang, X., Batty, I. H., Downes, C. P. (2002). Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells. J. Biol. Chem. 277: 338-344 [Abstract] [Full Text]  
  • Aguilar, Z., Slamon, D. J. (2001). The Transmembrane Heregulin Precursor Is Functionally Active. J. Biol. Chem. 276: 44099-44107 [Abstract] [Full Text]  
  • Moasser, M. M., Basso, A., Averbuch, S. D., Rosen, N. (2001). The Tyrosine Kinase Inhibitor ZD1839 (""Iressa"") Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Tumor Cells. Cancer Res. 61: 7184-7188 [Abstract] [Full Text]  
  • Park, S.-K., Miller, R., Krane, I., Vartanian, T. (2001). The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. JCB 154: 1245-1258 [Abstract] [Full Text]  
  • Lenferink, A. E. G., Busse, D., Flanagan, W. M., Yakes, F. M., Arteaga, C. L. (2001). ErbB2/neu Kinase Modulates Cellular p27Kip1 and Cyclin D1 through Multiple Signaling Pathways. Cancer Res. 61: 6583-6591 [Abstract] [Full Text]  
  • Lee, H., Akita, R. W., Sliwkowski, M. X., Maihle, N. J. (2001). A Naturally Occurring Secreted Human ErbB3 Receptor Isoform Inhibits Heregulin-stimulated Activation of ErbB2, ErbB3, and ErbB4. Cancer Res. 61: 4467-4473 [Abstract] [Full Text]  
  • Thor, A. D., Liu, S., Edgerton, S., Moore, D. II, Kasowitz, K. M., Benz, C. C., Stern, D. F., DiGiovanna, M. P. (2000). Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer. JCO 18: 3230-3239 [Abstract] [Full Text]  
  • Tang, C. K., Gong, X.-Q., Moscatello, D. K., Wong, A. J., Lippman, M. E. (2000). Epidermal Growth Factor Receptor vIII Enhances Tumorigenicity in Human Breast Cancer. Cancer Res. 60: 3081-3087 [Abstract] [Full Text]  
  • Patel, N. V., Acarregui, M. J., Snyder, J. M., Klein, J. M., Sliwkowski, M. X., Kern, J. A. (2000). Neuregulin-1 and Human Epidermal Growth Factor Receptors 2 and 3 Play a Role in Human Lung Development In Vitro. Am. J. Respir. Cell Mol. Bio. 22: 432-440 [Abstract] [Full Text]  
  • Miettinen, P., Huotari, M, Koivisto, T, Ustinov, J, Palgi, J, Rasilainen, S, Lehtonen, E, Keski-Oja, J, Otonkoski, T (2000). Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development 127: 2617-2627 [Abstract]  
  • Russell, K. S., Stern, D. F., Polverini, P. J., Bender, J. R. (1999). Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 277: H2205-H2211 [Abstract] [Full Text]  
  • Jones, F. E., Welte, T., Fu, X.-Y., Stern, D. F. (1999). Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during Lactation. JCB 147: 77-88 [Abstract] [Full Text]  
  • Muthuswamy, S. K., Gilman, M., Brugge, J. S. (1999). Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers. Mol. Cell. Biol. 19: 6845-6857 [Abstract] [Full Text]  
  • Saxon, M. L., Lee, D. C. (1999). Mutagenesis Reveals a Role for Epidermal Growth Factor Receptor Extracellular Subdomain IV in Ligand Binding. J. Biol. Chem. 274: 28356-28362 [Abstract] [Full Text]  
  • Polosa, R., Prosperini, G., Leir, S.-H., Holgate, S. T., Lackie, P. M., Davies, D. E. (1999). Expression of c-erbB Receptors and Ligands in Human Bronchial Mucosa. Am. J. Respir. Cell Mol. Bio. 20: 914-923 [Abstract] [Full Text]  
  • Klapper, L. N., Glathe, S., Vaisman, N., Hynes, N. E., Andrews, G. C., Sela, M., Yarden, Y. (1999). The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl. Acad. Sci. USA 96: 4995-5000 [Abstract] [Full Text]  
  • Bianco, C., Kannan, S., De Santis, M., Seno, M., Tang, C. K., Martinez-Lacaci, I., Kim, N., Wallace-Jones, B., Lippman, M. E., Ebert, A. D., Wechselberger, C., Salomon, D. S. (1999). Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation of erb B-4 through a Novel Receptor. J. Biol. Chem. 274: 8624-8629 [Abstract] [Full Text]  
  • Qian, X., O'Rourke, D. M., Fei, Z., Zhang, H.-T., Kao, C.-C., Greene, M. I. (1999). Domain-specific Interactions between the p185neu and Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes. J. Biol. Chem. 274: 574-583 [Abstract] [Full Text]  
  • Schaefer, G., Akita, R. W., Sliwkowski, M. X. (1999). A Discrete Three-amino Acid Segment (LVI) at the C-terminal End of Kinase-impaired ErbB3 Is Required for Transactivation of ErbB2. J. Biol. Chem. 274: 859-866 [Abstract] [Full Text]  
  • Felts, P. A. (1999). Neuregulins in Schwann Cell Development. Neuroscientist 5: 8-11 [Abstract]  
  • Sundaresan, S., Roberts, P. E., King, K. L., Sliwkowski, M. X., Mather, J. P. (1998). Biological Response to ErbB Ligands in Nontransformed Cell Lines Correlates with a Specific Pattern of Receptor Expression. Endocrinology 139: 4756-4764 [Abstract] [Full Text]  
  • Schroering, A., Carey, D. J. (1998). Sensory and Motor Neuron-derived Factor Is a Transmembrane Heregulin That Is Expressed on the Plasma Membrane with the Active Domain Exposed to the Extracellular Environment. J. Biol. Chem. 273: 30643-30650 [Abstract] [Full Text]  
  • Rahmatullah, M., Schroering, A., Rothblum, K., Stahl, R. C., Urban, B., Carey, D. J. (1998). Synergistic Regulation of Schwann Cell Proliferation by Heregulin and Forskolin. Mol. Cell. Biol. 18: 6245-6252 [Abstract] [Full Text]  
  • Niemann, C., Brinkmann, V., Spitzer, E., Hartmann, G., Sachs, M., Naundorf, H., Birchmeier, W. (1998). Reconstitution of Mammary Gland Development In Vitro: Requirement of c-met and c-erbB2 Signaling for Branching and Alveolar Morphogenesis. JCB 143: 533-545 [Abstract] [Full Text]  
  • Crovello, C. S., Lai, C., Cantley, L. C., Carraway III, K. L. (1998). Differential Signaling by the Epidermal Growth Factor-like Growth Factors Neuregulin-1 and Neuregulin-2. J. Biol. Chem. 273: 26954-26961 [Abstract] [Full Text]  
  • Pinkas-Kramarski, R., Shelly, M., Guarino, B. C., Wang, L. M., Lyass, L., Alroy, I., Alamandi, M., Kuo, A., Moyer, J. D., Lavi, S., Eisenstein, M., Ratzkin, B. J., Seger, R., Bacus, S. S., Pierce, J. H., Andrews, G. C., Yarden, Y. (1998). ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network. Mol. Cell. Biol. 18: 6090-6101 [Abstract] [Full Text]  
  • Britsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C., Riethmacher, D. (1998). The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev. 12: 1825-1836 [Abstract] [Full Text]  
  • Wang, L.-M., Kuo, A., Alimandi, M., Veri, M. C., Lee, C.-C., Kapoor, V., Ellmore, N., Chen, X.-H., Pierce, J. H. (1998). ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc. Natl. Acad. Sci. USA 95: 6809-6814 [Abstract] [Full Text]  
  • Cunnick, J. M., Dorsey, J. F., Standley, T., Turkson, J., Kraker, A. J., Fry, D. W., Jove, R., Wu, J. (1998). Role of Tyrosine Kinase Activity of Epidermal Growth Factor Receptor in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Pathway. J. Biol. Chem. 273: 14468-14475 [Abstract] [Full Text]  
  • Waterman, H., Sabanai, I., Geiger, B., Yarden, Y. (1998). Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency. J. Biol. Chem. 273: 13819-13827 [Abstract] [Full Text]  
  • Jones, J. T., Ballinger, M. D., Pisacane, P. I., Lofgren, J. A., Fitzpatrick, V. D., Fairbrother, W. J., Wells, J. A., Sliwkowski, M. X. (1998). Binding Interaction of the Heregulinbeta egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis. J. Biol. Chem. 273: 11667-11674 [Abstract] [Full Text]  
  • Riese II, D. J., Komurasaki, T., Plowman, G. D., Stern, D. F. (1998). Activation of ErbB4 by the Bifunctional Epidermal Growth Factor Family Hormone Epiregulin Is Regulated by ErbB2. J. Biol. Chem. 273: 11288-11294 [Abstract] [Full Text]  
  • Huotari, M.-A., Palgi, J., Otonkoski, T. (1998). Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel {beta}-Cell Mitogen. Endocrinology 139: 1494-1499 [Abstract] [Full Text]  
  • Fiddes, R. J., Campbell, D. H., Janes, P. W., Sivertsen, S. P., Sasaki, H., Wallasch, C., Daly, R. J. (1998). Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3. J. Biol. Chem. 273: 7717-7724 [Abstract] [Full Text]  
  • Eilam, R., Pinkas-Kramarski, R., Ratzkin, B. J., Segal, M., Yarden, Y. (1998). Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc. Natl. Acad. Sci. USA 95: 1888-1893 [Abstract] [Full Text]  
  • Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., Godowski, P. J. (1997). Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. USA 94: 9562-9567 [Abstract] [Full Text]  
  • Subramony, P., Dryer, S. E. (1997). Neuregulins stimulate the functional expression of Ca2+-activated K+ channels in developing chicken parasympathetic neurons. Proc. Natl. Acad. Sci. USA 94: 5934-5938 [Abstract] [Full Text]  
  • Kannan, S., De Santis, M., Lohmeyer, M., Riese, D. J. II, Smith, G. H., Hynes, N., Seno, M., Brandt, R., Bianco, C., Persico, G., Kenney, N., Normanno, N., Martinez-Lacaci, I., Ciardiello, F., Stern, D. F., Gullick, W. J., Salomon, D. S. (1997). Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells. J. Biol. Chem. 272: 3330-3335 [Abstract] [Full Text]  
  • Cohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., Zhang, K. (1996). The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. J. Biol. Chem. 271: 30897-30903 [Abstract] [Full Text]  
  • Riese, D. J. II, Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D., Stern, D. F. (1996). The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-alpha , Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271: 20047-20052 [Abstract] [Full Text]  
  • Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B. J., Yarden, Y. (1996). Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations. J. Biol. Chem. 271: 19029-19032 [Abstract] [Full Text]  
  • Vecchi, M., Baulida, J., Carpenter, G. (1996). Selective Cleavage of the Heregulin Receptor ErbB-4 by Protein Kinase C Activation. J. Biol. Chem. 271: 18989-18995 [Abstract] [Full Text]  
  • Carver, R. S., Sliwkowski, M. X., Sitaric, S., Russell, W. E. (1996). Insulin Regulates Heregulin Binding and ErbB3 Expression in Rat Hepatocytes. J. Biol. Chem. 271: 13491-13496 [Abstract] [Full Text]  
  • Sweeney, C., Fambrough, D., Huard, C., Diamonti, A. J., Lander, E. S., Cantley, L. C., Carraway, K. L. III (2001). Growth Factor-specific Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors. J. Biol. Chem. 276: 22685-22698 [Abstract] [Full Text]